Protein Chip Market Report 2026

The protein chip market size has grown strongly in recent years. It will grow from $1.73 billion in 2025 to $1.85 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to growth in proteomics research programs, increasing demand for high-throughput analytical tools, expansion of academic and clinical research laboratories, rising adoption of microarray technologies, availability of advanced surface chemistry techniques.

The protein chip market size is expected to see strong growth in the next few years. It will grow to $2.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing use of protein chips in diagnostics, rising investment in precision medicine platforms, expansion of point-of-care testing technologies, growing integration of AI-based data analysis, increasing demand for scalable proteomic tools. Major trends in the forecast period include increasing adoption of high-density protein microarrays, rising use of lab-on-chip protein platforms, growing integration of automated detection systems, expansion of multiplexed protein interaction analysis, enhanced focus on miniaturized diagnostic chips.

The increasing demand for personalized medicine is expected to drive the growth of the protein chip market in the coming years. Personalized medicine is an approach to healthcare that focuses on tailoring medical treatments and interventions to the specific needs of individual patients. The rise of personalized medicine is driven by rapid advances in omics technologies, data integration, genetics, and growing recognition of the importance of patient-specific therapies and preventive strategies. Protein chips play a key role in advancing personalized medicine by enabling large-scale proteomic analysis, supporting biomarker discovery, enhancing drug development and response evaluation, and facilitating the development of personalized therapeutic approaches. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six approvals in 2022. Therefore, the growing demand for personalized medicine is fueling the growth of the protein chip market.

Major companies operating in the protein chip market are focusing on the development of innovative solutions, such as automated parallel capillary electrophoresis systems, to strengthen their market presence. Automated parallel capillary electrophoresis systems are advanced analytical tools designed for high-throughput separation and analysis of biomolecules, particularly proteins and nucleic acids. For instance, in January 2024, Agilent Technologies Inc., a US-based manufacturer of advanced analytical, research, and diagnostic laboratory tools, introduced the ProteoAnalyzer system, an automated parallel capillary electrophoresis platform for protein analysis. The system features advanced algorithms for accurate protein identification and characterization, enabling deeper analysis of complex biological systems with high precision and efficiency. It also includes enhanced data visualization capabilities that support intuitive result interpretation and faster insights into cellular processes, along with seamless integration into existing laboratory workflows to improve productivity in proteomics research.

In March 2023, Spectrum Solutions LLC, a US-based company providing geospatial solutions, acquired MDx Lab Alimetrix and Array Maker Microarrays Inc. for an undisclosed amount. Through this acquisition, Spectrum Solutions aimed to expand its portfolio of laboratory products and testing capabilities, thereby strengthening its position in the diagnostics market. Microarrays Inc. is a US-based company specializing in protein and DNA microarray assays that use microarray technology for gene identification.

Major companies operating in the protein chip market are Thermo Fisher Scientific Inc, GE Healthcare LLC, Roche Diagnostics GmbH, Agilent Technologies Inc, Sigma Aldrich Corporation Merck, PerkinElmer Inc, Shimadzu Corporation, Bio Rad Laboratories Inc, Bruker Corporation, Surmodics Inc, OriGene Technologies Inc, RayBiotech Inc, Sengenics Corporation Pte Ltd, Gyros Protein Technologies AB, Innova Biosciences Limited, Innopsys SA, CDI Laboratories Inc, Microarrays Inc, Full Moon BioSystems Inc, Arrayit Corporation.

North America was the largest region in the global protein chip market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein chip market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the protein chip market by increasing costs of imported microfabrication materials, biochips, sensors, optical detection systems, and semiconductor-based components. Research institutions and diagnostic laboratories in North America and Europe are most affected due to dependence on specialized imported chips, while Asia-Pacific faces cost pressure on protein chip manufacturing exports. These tariffs are increasing development costs and slowing adoption in cost-sensitive research settings. At the same time, they are encouraging regional chip fabrication, domestic innovation, and localized production of protein microarray systems.

The protein chip market research report is one of a series of new reports that provides protein chip market statistics, including protein chip industry global market size, regional shares, competitors with a protein chip market share, detailed protein chip market segments, market trends and opportunities, and any further data you may need to thrive in the protein chip industry. This protein chip market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A protein chip is a high-throughput analytical tool designed to examine and analyze protein interactions, functions, and activities on a large scale. These chips operate through a sequence of steps that include immobilizing proteins on a solid surface, exposing them to samples or target molecules, and detecting and interpreting the resulting interactions or signals.

The primary products in the protein chip market include lab-on-chip systems, integrated systems, arrays, and microarray platforms. Lab-on-chip technology condenses and integrates multiple laboratory processes onto a single chip, allowing fast and efficient analysis of biological samples. The key technologies used in protein chips include analytical microarrays, functional protein microarrays, and reverse-phase protein microarrays. These technologies support applications such as diagnostics, proteomics, and antibody characterization, and are utilized by end users including hospitals and clinics, academic and research institutions, diagnostic laboratories, as well as pharmaceutical and biotechnology companies.

The protein chip market includes revenues earned by entities by providing services such as protein expression profiling, biomarker discovery, post-translational modification (PTM) analysis, quantitative and qualitative proteomics, and enzyme activity assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein chip market also includes sales of antibody arrays, protein arrays, peptide arrays, and full moon biosystems protein arrays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.